全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Exacerbated Hepatic, Splenic, and Neuropathology in BALB/c Mice Co-Infected with Leishmania major and Plasmodium berghei

DOI: 10.4236/ojpathology.2025.154016, PP. 196-215

Keywords: Malaria, Leishmaniasis, Co-Infection, Pathology, BALB/c Mice

Full-Text   Cite this paper   Add to My Lib

Abstract:

Co-infection with multiple protozoan parasites is a frequent yet understudied phenomenon. Leishmania major and Plasmodium berghei evoke distinct immune responses that may interact during co-infection to alter disease progression. This study aimed to evaluate the histopathological implications in BALB/c mice concurrently infected with L. major and P. berghei. One hundred sixty BALB/c mice were assigned to four groups: na?ve, L. major-only, P. berghei-only, and co-infected. Body weight, parasitemia, parasite burden, and complete blood count (CBC) were monitored. Spleen and brain tissues were harvested, fixed, and examined histologically. Comparative assessments were made against na?ve controls. Histopathological evaluation of BALB/c mice revealed that co-infection with Leishmania major and Plasmodium berghei induced more severe and widespread organ damage than single infections with either parasite. In the liver, co-infected mice exhibited extensive granuloma formation, diffuse infiltration of immune cells, hepatocyte degeneration, and vascular congestion. Splenic sections showed complete loss of red/white pulp boundaries, massive lymphoid follicle hypertrophy, dense leukocytic infiltration, abundant megakaryocytes, fibrosis, and pronounced hemozoin deposition. Brain tissue analysis demonstrated severe blood-brain barrier disruption, widespread hemorrhage, intense microgliosis, granuloma formation, and marked neuronal degeneration. Notably, certain neuroinflammatory and systemic pathological features—particularly extensive CNS involvement in L. major infection—have not been previously reported. These findings highlight the synergistic exacerbation of tissue injury in co-infection and underscore the need for integrated control strategies in regions where leishmaniasis and malaria are co-endemic. The findings demonstrate that co-infection with L. major and P. berghei leads to exacerbated disease manifestations and altered immune homeostasis.

References

[1]  Kaminsky, R. and Mäser, P. (2025) Global Impact of Parasitic Infections and the Importance of Parasite Control. Frontiers in Parasitology, 4, Article 1546195.
https://doi.org/10.3389/fpara.2025.1546195
[2]  Oryan, A. and Akbari, M. (2016) Worldwide Risk Factors in Leishmaniasis. Asian Pacific Journal of Tropical Medicine, 9, 925-932.
https://doi.org/10.1016/j.apjtm.2016.06.021
[3]  Pinna, R.A., Silva-dos-Santos, D., Perce-da-Silva, D.S., Oliveira-Ferreira, J., Villa-Verde, D.M.S., De Luca, P.M., et al. (2016) Malaria-Cutaneous Leishmaniasis Co-Infection: Influence on Disease Outcomes and Immune Response. Frontiers in Microbiology, 7, Article 982.
https://doi.org/10.3389/fmicb.2016.00982
[4]  Torres-Guerrero, E., Quintanilla-Cedillo, M.R., Ruiz-Esmenjaud, J. and Arenas, R. (2017) Leishmaniasis: A Review. F1000Research, 6, Article 750.
https://doi.org/10.12688/f1000research.11120.1
[5]  Otun, O. and Achilonu, I. (2025) Plasmodium yoelii as a Model for Malaria: Insights into Pathogenesis, Drug Resistance, and Vaccine Development. Molecular Biology Reports, 52, Article No. 208.
https://doi.org/10.1007/s11033-025-10318-4
[6]  Leitner, W.W., Bergmann-Leitner, E.S. and Angov, E. (2010) Comparison of Plasmodium berghei Challenge Models for the Evaluation of Pre-Erythrocytic Malaria Vaccines and Their Effect on Perceived Vaccine Efficacy. Malaria Journal, 9, Article No. 145.
https://doi.org/10.1186/1475-2875-9-145
[7]  Ayako, R.M., Mutiso, J.M., Macharia, J.C., Langoi, D. and Ochola, L. (2021) Concomitant Infection with Leishmania donovani and Plasmodium berghei Causes Pro-Inflammatory Polarization Resulting in Malaria Exacerbation in BALB/c Mice. American Journal of Infectious Diseases and Microbiology, 9, 71-82.
https://doi.org/10.12691/ajidm-9-3-1
[8]  Spencer, L.M., Peña-Quintero, A., Canudas, N., Bujosa, I. and Urdaneta, N. (2018) Antimalarial Effect of Two Photo-Excitable Compounds in a Murine Model with Plasmodium berghei (Haemosporida: Plasmodiidae). Revista de Biología Tropical, 66, 880-891.
https://doi.org/10.15517/rbt.v66i2.33420
[9]  Quadros Gomes, A.R., Castro, A.L.G., Ferreira, G.G., Brígido, H.P.C., Varela, E.L.P., Vale, V.V., et al. (2024) Impact on Parasitemia, Survival Time and Pro-Inflammatory Immune Response in Mice Infected with Plasmodium berghei Treated with Eleutherine plicata. Frontiers in Pharmacology, 15, Article 1484934.
https://doi.org/10.3389/fphar.2024.1484934
[10]  Mutiso, J.M., Macharia, J.C. and Gicheru, M.M. (2012) Immunization with Leishmania Vaccine-Alum-BCG and Montanide ISA 720 Adjuvants Induces Low-Grade Type 2 Cytokines and High Levels of Igg2 Subclass Antibodies in the Vervet Monkey (Chlorocebus aethiops) Model. Scandinavian Journal of Immunology, 76, 471-477.
https://doi.org/10.1111/j.1365-3083.2012.02764.x
[11]  Kaye, P. and Scott, P. (2011) Leishmaniasis: Complexity at the Host-Pathogen Interface. Nature Reviews Microbiology, 9, 604-615.
https://doi.org/10.1038/nrmicro2608
[12]  Lockwood, D. and Moore, E. (2010) Treatment of Visceral Leishmaniasis. Journal of Global Infectious Diseases, 2, 151-158.
https://doi.org/10.4103/0974-777x.62883
[13]  Salguero, F.J., Garcia-Jimenez, W.L., Lima, I. and Seifert, K. (2018) Histopathological and Immunohistochemical Characterisation of Hepatic Granulomas in Leishmania donovani-Infected BALB/c Mice: A Time-Course Study. Parasites & Vectors, 11, Article No. 73.
https://doi.org/10.1186/s13071-018-2624-z
[14]  Deroost, K., Pham, T., Opdenakker, G. and Van den Steen, P.E. (2015) The Immunological Balance between Host and Parasite in Malaria. FEMS Microbiology Reviews, 40, 208-257.
https://doi.org/10.1093/femsre/fuv046
[15]  Scaccabarozzi, D., Deroost, K., Corbett, Y., Lays, N., Corsetto, P., Salè, F.O., et al. (2018) Differential Induction of Malaria Liver Pathology in Mice Infected with Plasmodium chabaudi as or Plasmodium berghei NK65. Malaria Journal, 17, Article No. 18.
https://doi.org/10.1186/s12936-017-2159-3
[16]  Ornellas-Garcia, U., Freire-Antunes, L., Rangel-Ferreira, M., de Sousa, C.H.G., Ribeiro-Almeida, M.L., Daniel-Ribeiro, C.T., et al. (2025) Impact of Co-Infection with Plasmodium berghei ANKA in Leishmania Major-Parasitized Mice on Immune Modulation and Cutaneous Leishmaniasis. PLOS Neglected Tropical Diseases, 19, e0013302.
https://doi.org/10.1371/journal.pntd.0013302
[17]  Wang, M., Feng, Y., Pang, W., Qi, Z., Zhang, Y., Guo, Y., et al. (2014) Parasite Densities Modulate Susceptibility of Mice to Cerebral Malaria during Co-Infection with Schistosoma japonicum and Plasmodium berghei. Malaria Journal, 13, Article No. 116.
https://doi.org/10.1186/1475-2875-13-116
[18]  Maspi, N., Abdoli, A. and Ghaffarifar, F. (2016) Pro-and Anti-Inflammatory Cytokines in Cutaneous Leishmaniasis: A Review. Pathogens and Global Health, 110, 247-260.
https://doi.org/10.1080/20477724.2016.1232042
[19]  Maksoud, S. and El Hokayem, J. (2023) The Cytokine/Chemokine Response in Leishmania/HIV Infection and Co-infection. Heliyon, 9, e15055.
https://doi.org/10.1016/j.heliyon.2023.e15055
[20]  Murphy, M.L., Wille, U., Villegas, E.N., Hunter, C.A. and Farrell, J.P. (2001) IL-10 Mediates Susceptibility to Leishmania donovani Infection. European Journal of Immunology, 31, 2848-2856.
[21]  Dayakar, A., Chandrasekaran, S., Kuchipudi, S.V. and Kalangi, S.K. (2019) Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy. Frontiers in Immunology, 10, Article 670.
https://doi.org/10.3389/fimmu.2019.00670
[22]  Santana, C.C., de Freitas, L.A.R., Oliveira, G.G.S. and dos-Santos, W.L.C. (2019) Disorganization of Spleen Compartments and Dermatitis in Canine Visceral Leishmaniasis. Surgical and Experimental Pathology, 2, Article No. 14.
https://doi.org/10.1186/s42047-019-0040-0
[23]  Delahunt, C., Horning, M.P., Wilson, B.K., Proctor, J.L. and Hegg, M.C. (2014) Limitations of Haemozoin-Based Diagnosis of Plasmodium falciparum Using Dark-Field Microscopy. Malaria Journal, 13, Article No. 147.
https://doi.org/10.1186/1475-2875-13-147
[24]  Chadburn, A., Abdul-Nabi, A.M., Teruya, B.S. and Lo, A.A. (2013) Lymphoid Proliferations Associated with Human Immunodeficiency Virus Infection. Archives of Pathology & Laboratory Medicine, 137, 360-370.
https://doi.org/10.5858/arpa.2012-0095-ra
[25]  Prasad, S., Sheng, W.S., Hu, S., Chauhan, P. and Lokensgard, J.R. (2021) Dysregulated Microglial Cell Activation and Proliferation Following Repeated Antigen Stimulation. Frontiers in Cellular Neuroscience, 15, Article 686340.
https://doi.org/10.3389/fncel.2021.686340
[26]  Samant, M., Sahu, U., Pandey, S.C. and Khare, P. (2021) Role of Cytokines in Experimental and Human Visceral Leishmaniasis. Frontiers in Cellular and Infection Microbiology, 11, Article 624009.
https://doi.org/10.3389/fcimb.2021.624009
[27]  Andoh, N.E. and Gyan, B.A. (2021) The Potential Roles of Glial Cells in the Neuropathogenesis of Cerebral Malaria. Frontiers in Cellular and Infection Microbiology, 11, Article 741370.
https://doi.org/10.3389/fcimb.2021.741370
[28]  de Oca, M.M., Engwerda, C. and Haque, A. (2013) Plasmodium berghei ANKA (PbA) Infection of C57BL/6J Mice: A Model of Severe Malaria. In: Allen, I., Ed., Mouse Models of Innate Immunity, Humana Press, 203-213.
https://doi.org/10.1007/978-1-62703-481-4_23
[29]  Devi, P., Khan, A., Chattopadhyay, P., Mehta, P., Sahni, S., Sharma, S., et al. (2021) Co-Infections as Modulators of Disease Outcome: Minor Players or Major Players? Frontiers in Microbiology, 12, Article 664386.
https://doi.org/10.3389/fmicb.2021.664386
[30]  Mabbott, N.A. (2018) The Influence of Parasite Infections on Host Immunity to Co-Infection with Other Pathogens. Frontiers in Immunology, 9, Article 2579.
https://doi.org/10.3389/fimmu.2018.02579

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133